Roche Loses Appeal Against Generic Co. At China's Top Court

By Andrew Karpan (August 29, 2022, 8:20 PM EDT) -- China's highest court has reportedly ruled for the first time on the country's new "patent linkage" system, signing off on a ruling from an intellectual property court in Beijing finding that a generic osteoporosis drug did not infringe a patent owned by a Japanese Roche subsidiary....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!